A Pilot Test of the Relaxation Response Resiliency Program (3RP) in Spanish Speaking World Trade Center Survivors With Post Traumatic Stress Disorder (PTSD)
1 other identifier
interventional
20
1 country
1
Brief Summary
The objective of this protocol is to test the feasibility and acceptability of the Relaxation Response Resiliency Program (3RP), a psychotherapy treatment providing a variety of mind body skills and interventions to decrease medical and mental health symptoms and build resilience, in Spanish-speaking World Trade Center (WTC) survivors, and to examine its clinical effectiveness to reduce Post Traumatic Stress Disorder (PTSD), depression, anxiety, and lower respiratory symptoms (LRS) and improve psychosocial functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 24, 2016
CompletedFirst Posted
Study publicly available on registry
March 30, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 11, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 11, 2017
CompletedOctober 18, 2017
October 1, 2017
1.6 years
March 24, 2016
October 16, 2017
Conditions
Outcome Measures
Primary Outcomes (7)
Structured Clinical Interview (SCID-NP) for Diagnostic and Statistical Manual DSM-IV
State-of-the-art instrument for obtaining psychiatric diagnoses.
1 Month
Symptom Severity using PTSD Checklist
Symptoms will be assessed with the PTSD Checklist (PCL), a 17-item self-report measure of current (past month) PTSD symptoms based on the DSM-IV criteria. It is a widely-used and validated measure of PTSD symptom severity.
1 Month
Assessment of Anxiety Symptoms using Generalized Anxiety Disorder Scale (GAD-7)
1 Month
Measure of Functional Impairment using the Range of Impaired Functioning Tool (RIFT)
widely-used instrument that taps the domains of work, household duties, interpersonal relationships, recreation, and subjective satisfaction with life. Each domain is rated on a five-point scale from very good to very poor. The total score is the sum of the different domains.
1 Month
Assessment of Mindful attention using Mindful Attention Awareness Scale (MAAS)
The MAAS is a 15-item questionnaire on which respondents indicate, on a 6 point Likert-type scale (1 = almost always to 6 = almost never), their level of awareness and attention to present events and experiences.
1 Month
Health Promoting Behaviors will be assessed with the Health Promoting Lifestyles Profile-II (HPLP-II)
he HPLP-II is a 52 item self-report inventory of health behaviors and has been used in previous mind-body treatment studies
1 Month
Measure of treatment expectancy using the Treatment Credibility/Expectancy Questionnaire.
The 6-item Treatment Credibility/Expectancy Questionnaire (CEQ)84 will be used to examine treatment expectancy related to the 3RP.
1 Month
Study Arms (1)
Relaxation Response Resiliency Program (3RP)
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- score \> or = 44 on the PTSD Checklist PCL, considered the broad definition of PTSD syndrome71
- report at least one LRS symptoms (i.e., shortness of breath, wheezing, dyspnea or cough).
- Spanish Speaking
You may not qualify if:
- regular practice of eliciting relaxation response (i.e., meditation, yoga) in the past 6 months,
- serious unmanaged mental illness including bipolar disorder, psychosis, and active substance misuse disorders;
- inability to participate in consecutive sessions over 3-month period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lucia Ferri, MD
New York University Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2016
First Posted
March 30, 2016
Study Start
March 1, 2016
Primary Completion
October 11, 2017
Study Completion
October 11, 2017
Last Updated
October 18, 2017
Record last verified: 2017-10